In addition, similar to the data of HC, the increase in Th17, Th17/Th1 cells and IL-17 production in RA patients triggered by LPS-activated monocytes could be suppressed by adding anti-CD147 mAb (Figures 4D, E). Here, IL17A is linked to rheumatoid arthritis.